US 9504683
Heteroaryl derivatives as CFTR modulators
granted A61KA61K31/443A61K31/497
Quick answer
US patent 9504683 (Heteroaryl derivatives as CFTR modulators) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61K, A61K31/443, A61K31/497, A61K31/501, A61K31/506